Related Experiment Video
Updated: Jun 23, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas
Anita C Bellail1, Margaret C L Tse, Jin H Song
1Department of Pathology and Laboratory Medicine, Winship Cancer Institute, Emory University School Medicine, Atlanta, GA 30322, USA.
Abstract:
To explore the molecular mechanisms by which glioblastomas are resistant to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), we examined TRAIL signalling pathways in the tumours. TRAIL has four membrane-anchored receptors, death receptor 4/5 (DR4/5) and decoy receptor 1/2 (DcR1/2). Of these receptors, only DR5 was expressed consistently in glioblastoma cell lines and tumour tissues, ruling out the role of DcR1/2 in TRAIL resistance. Upon TRAIL binding, DR5 was homotrimerized and recruited Fas-associated death domain (FADD) and caspase-8 for the assembly of death-inducing signalling complex (DISC) in the lipid rafts of the plasma membrane. In the DISC, caspase-8 was cleaved and initiated apoptosis by cleaving downstream caspases in TRAIL-sensitive glioblastoma cells. In TRAIL-resistant cells, however, DR5-mediated DISC was modified by receptor-interacting protein (RIP), cellular FADD-like interleukin-1beta-converting enzyme inhibitory protein (c-FLIP) and phosphoprotein enriched in diabetes or in astrocyte-15 (PED/PEA-15). This DISC modification occurred in the non-raft fractions of the plasma membrane and resulted in the inhibition of caspase-8 cleavage and activation of nuclear factor-kappaB (NF-kappaB). Treatment of resistant cells with parthenolide, an inhibitor of inhibitor of kappaB (I-kappaB), eliminated TRAIL-induced NF-kappaB activity but not TRAIL resistance. In contrast, however, targeting of RIP, c-FLIP or PED/PEA-15 with small interfering RNA (siRNA) led to the redistribution of the DISC from non-rafts to lipid rafts and eliminated the inhibition of caspase-8 cleavage and thereby TRAIL resistance. Taken together, this study indicates that the DISC modification by RIP, c-FLIP and PED/PEA-15 is the most upstream event in TRAIL resistance in glioblastomas.
Insights
Glioblastomas resist TRAIL-induced apoptosis due to modified death-inducing signaling complexes (DISCs) involving RIP, c-FLIP, and PED/PEA-15. Inhibiting these factors restores DISC function and TRAIL sensitivity in glioblastoma cells.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Research
Background:
- Glioblastomas often exhibit resistance to apoptosis-inducing agents like tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
- Understanding the molecular mechanisms of TRAIL resistance is crucial for developing effective glioblastoma therapies.
Purpose of the Study:
- To elucidate the molecular pathways conferring TRAIL resistance in glioblastomas.
- To identify key molecular players involved in the dysregulation of TRAIL signaling in resistant glioblastoma cells.
Main Methods:
- Analysis of TRAIL receptor expression (DR4/5, DcR1/2) in glioblastoma cell lines and tissues.
- Investigation of death-inducing signaling complex (DISC) assembly and composition in TRAIL-sensitive versus resistant cells.
- Utilized small interfering RNA (siRNA) to target specific proteins (RIP, c-FLIP, PED/PEA-15) and assessed the impact on TRAIL sensitivity.
Main Results:
- Death receptor 5 (DR5) is consistently expressed in glioblastomas, while decoy receptors are not implicated in resistance.
- In resistant cells, the DISC is modified by receptor-interacting protein (RIP), cellular FADD-like interleukin-1beta-converting enzyme inhibitory protein (c-FLIP), and phosphoprotein enriched in diabetes or in astrocyte-15 (PED/PEA-15) in non-raft membrane fractions.
- This modification inhibits caspase-8 activation and promotes nuclear factor-kappaB (NF-kappaB) activity, leading to TRAIL resistance.
- Targeting RIP, c-FLIP, or PED/PEA-15 with siRNA restored DISC function in lipid rafts, enabling caspase-8 cleavage and overcoming TRAIL resistance.
Conclusions:
- DISC modification by RIP, c-FLIP, and PED/PEA-15 is the primary upstream event driving TRAIL resistance in glioblastomas.
- These proteins disrupt DISC assembly in lipid rafts, preventing caspase-8 activation and subsequent apoptosis.
- Targeting these specific proteins represents a potential therapeutic strategy to re-sensitize glioblastomas to TRAIL-based therapies.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Caspases
The Intrinsic Apoptotic Pathway
Apoptosis

